Meyer Colin John

Officer at REATA PHARMACEUTICALS INC

Sold, on record
$26.4M
Dollars the filings state
Form 4 sales
7
Latest Aug 16, 2023
Form 144 notices
4
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale REATA PHARMACEUTICALS INCUnusual
    Mar 3 2023

    Sold 93,922 shares at $86.72 ($8.1M)

    Meyer Colin John, Chief Innovation Officer

    Sold 52.4% of holdings ($15.5M position)85,227 shares leftFiling

  2. 2 Form 4 sale REATA PHARMACEUTICALS INCPlan not stated
    Mar 7 +4 days

    Sold 621 shares at $84.57 ($53k)

    Meyer Colin John, Chief Innovation Officer

    Sold 0.7% of holdings ($7.2M position)84,606 shares leftFiling

  3. 3 Form 144 notice REATA PHARMACEUTICALS INCNotice
    May 15 +69 days

    Filed to sell 5,608 shares ($476k)

    Meyer Colin John, Officer

    No 10b5-1 plan0.1x usual sizeFiling

  4. 4 Form 144 notice REATA PHARMACEUTICALS INCNotice
    May 16 +1 day

    Filed to sell 625 shares ($51k)

    Meyer Colin John, Officer

    No 10b5-1 plan0x usual sizeFiling

  5. 5 Form 4 sale REATA PHARMACEUTICALS INCNo plan
    May 16 same day

    Sold 6,233 shares at $84.56 ($527k)

    Meyer Colin John, Chief Innovation Officer

    No 10b5-1 planSold 7.4% of holdings ($7.2M position)78,373 shares left0.1x usual sizeFollows a Form 144Filing

  6. 6 Form 144 notice REATA PHARMACEUTICALS INCNotice
    Aug 15 +91 days

    Filed to sell 2,144 shares ($362k)

    Meyer Colin John, Officer

    No 10b5-1 plan0.3x usual sizeFiling

  7. 7 Form 144 notice REATA PHARMACEUTICALS INCNotice
    Aug 16 +1 day

    Filed to sell 596 shares ($101k)

    Meyer Colin John, Officer

    No 10b5-1 plan0.1x usual sizeFiling

  8. 8 Form 4 sale REATA PHARMACEUTICALS INCNo plan
    Aug 16 same day

    Sold 2,740 shares at $169.00 ($463k)

    Meyer Colin John, Chief Innovation Officer

    No 10b5-1 planSold 3.2% of holdings ($14.3M position)81,633 shares left0.4x usual sizeFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (11)

Form 144 notices and Form 4 sales by Meyer Colin John
Source
Aug 16, 2023REATA PHARMACEUTICALS INCChief Innovation OfficerForm 4 sale2,740$463k3.2%No planSEC
Aug 16, 2023REATA PHARMACEUTICALS INCOfficerForm 144 notice596$101kNoticeSEC
Aug 15, 2023REATA PHARMACEUTICALS INCOfficerForm 144 notice2,144$362kNoticeSEC
May 16, 2023REATA PHARMACEUTICALS INCChief Innovation OfficerForm 4 sale6,233$527k7.4%No planSEC
May 16, 2023REATA PHARMACEUTICALS INCOfficerForm 144 notice625$51kNoticeSEC
May 15, 2023REATA PHARMACEUTICALS INCOfficerForm 144 notice5,608$476kNoticeSEC
Mar 7, 2023REATA PHARMACEUTICALS INCChief Innovation OfficerForm 4 sale621$53k0.7%Plan not statedSEC
Mar 3, 2023REATA PHARMACEUTICALS INCChief Innovation OfficerForm 4 sale93,922$8.1M52.4%UnusualSEC
Jun 15, 2021REATA PHARMACEUTICALS INCChief Research OfficerForm 4 sale60,000$8.6M77.9%UnusualSEC
Nov 17, 2020REATA PHARMACEUTICALS INCChief Research OfficerForm 4 sale25,000$4.2M25.8%UnusualSEC
Nov 9, 2020REATA PHARMACEUTICALS INCChief Research OfficerForm 4 sale25,000$4.4M25.8%UnusualSEC